Odyssey Therapeutics, Inc.(ODTX)
$20.99+0.99 (+4.95%)
ODTX
Odyssey Therapeutics, Inc. stock drug pipeline
$20.99
At close:+0.99 (+4.95%)
Odyssey Therapeutics, Inc. (ODTX) Drug Pipeline
14 Followers
| Drug Name | Condition | Stage | Status | Study Name | Trial Start Date | Article |
|---|---|---|---|---|---|---|
| [14C]Od-001 | Health Volunteers | Phase I | Recruiting | The Mass Balance Recovery, Metabolite Profile and Metabolite Identification of [14C]OD-001 in Healthy Male Participants | Oct 05, 2026 | ― |
| Drug Name | Stage | Condition | Status | Study Name | Trial Start Date | Article |
|---|---|---|---|---|---|---|
| [14C]Od-001 | Phase I | Health Volunteers | Recruiting | The Mass Balance Recovery, Metabolite Profile and Metabolite Identification of [14C]OD-001 in Healthy Male Participants | Oct 05, 2026 | ― |
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Odyssey Therapeutics, Inc. (ODTX) have in its pipeline
Odyssey Therapeutics, Inc. ODTX is currently developing the following drugs: [14C]Od-001. These drug candidates are in various stages of clinical development as the company works toward FDA approval.
